| Product Code: ETC8622764 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Nigeria continued to rely on key suppliers such as India, China, and the Netherlands for cyclosporine imports. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the compound annual growth rate (CAGR) for 2020-2024 decreased significantly by -26.13%. Furthermore, the growth rate from 2023 to 2024 saw a decline of -30.33%, suggesting a challenging market environment for cyclosporine import shipments into Nigeria. Monitoring these trends will be crucial for stakeholders in the pharmaceutical industry to navigate potential market shifts effectively.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Cyclosporine Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Cyclosporine Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Cyclosporine Market - Industry Life Cycle |
3.4 Nigeria Cyclosporine Market - Porter's Five Forces |
3.5 Nigeria Cyclosporine Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Nigeria Cyclosporine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Nigeria Cyclosporine Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Nigeria Cyclosporine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Nigeria Cyclosporine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Nigeria |
4.2.2 Growing demand for organ transplants in the country |
4.2.3 Rising healthcare expenditure and infrastructure development in Nigeria |
4.3 Market Restraints |
4.3.1 High cost of cyclosporine medication |
4.3.2 Limited availability of specialized healthcare facilities for cyclosporine treatment |
4.3.3 Stringent regulatory requirements for importing and distributing pharmaceutical products in Nigeria |
5 Nigeria Cyclosporine Market Trends |
6 Nigeria Cyclosporine Market, By Types |
6.1 Nigeria Cyclosporine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Cyclosporine Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Nigeria Cyclosporine Market Revenues & Volume, By Transplant Rejection Prophylaxis, 2021- 2031F |
6.1.4 Nigeria Cyclosporine Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.1.5 Nigeria Cyclosporine Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.1.6 Nigeria Cyclosporine Market Revenues & Volume, By Autoimmune Myasthenia Gravis, 2021- 2031F |
6.1.7 Nigeria Cyclosporine Market Revenues & Volume, By Dry Eye, 2021- 2031F |
6.1.8 Nigeria Cyclosporine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Nigeria Cyclosporine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Cyclosporine Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Nigeria Cyclosporine Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 Nigeria Cyclosporine Market Revenues & Volume, By Topical, 2021- 2031F |
6.3 Nigeria Cyclosporine Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Cyclosporine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Nigeria Cyclosporine Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Nigeria Cyclosporine Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 Nigeria Cyclosporine Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Nigeria Cyclosporine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Cyclosporine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Nigeria Cyclosporine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Nigeria Cyclosporine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Nigeria Cyclosporine Market Import-Export Trade Statistics |
7.1 Nigeria Cyclosporine Market Export to Major Countries |
7.2 Nigeria Cyclosporine Market Imports from Major Countries |
8 Nigeria Cyclosporine Market Key Performance Indicators |
8.1 Patient adherence rate to cyclosporine treatment regimen |
8.2 Number of healthcare professionals trained in prescribing and monitoring cyclosporine therapy |
8.3 Rate of adoption of new formulations or delivery methods for cyclosporine therapy |
8.4 Patient satisfaction and reported outcomes with cyclosporine treatment |
8.5 Number of clinical trials and research studies conducted on cyclosporine efficacy and safety in Nigeria |
9 Nigeria Cyclosporine Market - Opportunity Assessment |
9.1 Nigeria Cyclosporine Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Nigeria Cyclosporine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Nigeria Cyclosporine Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Nigeria Cyclosporine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Nigeria Cyclosporine Market - Competitive Landscape |
10.1 Nigeria Cyclosporine Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Cyclosporine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |